Proteomics profiling identify CAPS as a potential predictive marker of tamoxifen resistance in estrogen receptor positive breast cancer.
about
Expression of Myxovirus Resistance A (MxA) Is Associated with Tumor-Infiltrating Lymphocytes in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancers.AHNAK2 is a potential prognostic biomarker in patients with PDAC.Multivariate models from RNA-Seq SNVs yield candidate molecular targets for biomarker discovery: SNV-DALoss of GFAT1 promotes epithelial-to-mesenchymal transition and predicts unfavorable prognosis in gastric cancer.Cell surface protease activation during RAS transformation: Critical role of the plasminogen receptor, S100A10.The ninth ENBDC Weggis meeting: growth and in-depth characterisation of normal and neoplastic breast cells.Functional proteomics outlines the complexity of breast cancer molecular subtypes.Invalidation of mitophagy by FBP1-mediated repression promotes apoptosis in breast cancer.Comprehensive single-cell transcriptome analysis reveals heterogeneity in endometrioid adenocarcinoma tissues.Overexpression of calcyphosine is associated with poor prognosis in esophageal squamous cell carcinoma.Discovery of Tamoxifen and N-Desmethyl Tamoxifen Protein Targets in MCF-7 Cells Using Large-Scale Protein Folding and Stability Measurements.Targeting FBPase is an emerging novel approach for cancer therapy.
P2860
Q33584106-D062660A-E8DE-49CC-A3C6-AB0F5ABF241BQ33761904-8588AE08-B9DB-4756-A5A9-FF544E07C278Q35974524-A5676113-AC9A-4A53-9659-6C138C1D9693Q37437526-3FDC938B-3FAD-48D9-A42C-BCD210A189ABQ40860086-0A67B628-A456-4AD9-A27A-43C42ECE40A8Q41498742-84E4A2E7-F025-4F2D-9E83-C81D3FCE831FQ41564586-61D34120-070A-44BE-A1BD-1F0D77634343Q46344001-E5C0889E-111C-433E-AADF-8709C882C643Q47120951-4EDD50B1-CA94-44C7-98A5-4370F49DAF4DQ47134688-809E61AE-651B-47BC-AC3D-E61DA0B4420AQ47777575-D02316E8-5A64-4300-969F-88A18717684EQ52647812-1ACE0D58-03F3-44C6-A67C-278ACD6C9550
P2860
Proteomics profiling identify CAPS as a potential predictive marker of tamoxifen resistance in estrogen receptor positive breast cancer.
description
2015 nî lūn-bûn
@nan
2015 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մարտին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Proteomics profiling identify ...... ceptor positive breast cancer.
@ast
Proteomics profiling identify ...... ceptor positive breast cancer.
@en
type
label
Proteomics profiling identify ...... ceptor positive breast cancer.
@ast
Proteomics profiling identify ...... ceptor positive breast cancer.
@en
prefLabel
Proteomics profiling identify ...... ceptor positive breast cancer.
@ast
Proteomics profiling identify ...... ceptor positive breast cancer.
@en
P2093
P2860
P50
P1433
P1476
Proteomics profiling identify ...... ceptor positive breast cancer.
@en
P2093
Barbro K Linderholm
Betzabe C Sanchez
Helena Fohlin
Jenny Forshed
Jonas Bergh
Rolf Lewensohn
P2860
P2888
P356
10.1186/S12014-015-9080-Y
P577
2015-03-21T00:00:00Z
P5875
P6179
1007683605